Chaim Hurvitz - 09 Apr 2025 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role: Director
Signature: /s/ Chaim Hurvitz
Issuer symbol: NRXP
Transactions as of: 09 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 10 Sep 2025, 15:35:00 UTC
Previous filing: 25 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hurvitz Chaim	Director	C/O NRX PHARMACEUTICALS, INC., 1201 ORANGE AVENUE, SUITE 600, WILMINGTON	/s/ Chaim Hurvitz	10 Sep 2025	0001630542

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRXP	Stock Option (right to buy)	Award	$0	+25,000		$0.000000	25,000	09 Apr 2025	Common Stock	25,000	$1.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest on April 9, 2026, subject to continued service to the Issuer.